How BrainChip’s Neuromorphic AI Is Powering Space and Defense Breakthroughs

Commercial Momentum Builds

BrainChip Holdings Ltd (ASX: BRN) has continued to build on its momentum in the first quarter of 2025, securing pivotal contracts and partnerships that underscore its leadership in neuromorphic artificial intelligence technology. The highlight was the Swedish National Space Agency's contract awarded to Frontgrade Gaisler to commercialize the first neuromorphic System on Chip (SoC) device for space applications, integrating BrainChip's Akida™ technology. This collaboration aims to deliver energy-efficient AI solutions tailored for the stringent demands of space missions.

Complementing this, BrainChip secured a US$1.8 million contract from the U.S. Air Force Research Laboratory under the SBIR program, focusing on neuromorphic radar signal processing. The involvement of defense giant Raytheon as a subcontractor adds significant weight to this initiative, potentially opening doors to broader defense applications.

Innovative Partnerships and Product Demonstrations

Beyond government contracts, BrainChip has forged a technology partnership with Oman-based Onsor Technologies to develop a wearable device for epileptic seizure prediction. Leveraging the Akida platform, this solution combines EEG sensors with neuromorphic processing to achieve high accuracy and continuous learning capabilities, marking a promising healthcare application of BrainChip’s technology.

Marketing efforts were also evident at Embedded World 2025 in Germany, where BrainChip showcased its Akida 2.0 processor's gesture recognition capabilities in conjunction with Prophesee’s event-based camera. This demonstration highlighted the potential for ultra-low power, low-latency AI applications in areas such as autonomous vehicles and industrial automation.

Corporate Strategy and Financial Position

On the corporate front, BrainChip is considering redomiciling to the United States, a move that could lead to delisting from the ASX and relisting on a US exchange. While no formal decision has been made, the Board is engaging shareholders on the potential benefits, signaling a strategic pivot to better align with its global operations and investor base.

Financially, the company ended the quarter with a cash balance of US$16.98 million, down from US$20 million in the previous quarter. Operating cash outflows remained steady at US$4.1 million, with increased payments reflecting employee incentives. Fundraising efforts continue through a Put Option Agreement with LDA Capital and stock option exercises, providing a runway of approximately 4.3 quarters based on current cash burn.

BrainChip’s global footprint spans Australia, the United States, France, and India, positioning it well to capitalize on emerging AI opportunities across diverse markets.

Looking Ahead

CEO Tony Dawe acknowledged the slower-than-expected pace of closing commercial engagements but expressed confidence in accelerating bookings throughout 2025. With a strong pipeline of contracts and partnerships, BrainChip is poised to advance its neuromorphic AI technology into new sectors and geographies.